GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Role of obesity as a causative factor of breast cancer in women of African American ethnicity

$365,447
Deepa Bedi · Tuskegee University · U54 · FY2024 · MD

Project 4: Activity of CAR T cell Therapy for Patients with Metastatic TNBC

$365,428
Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA

Visualizing tumor heterogeneity in an immune intact and autochthonous mouse model of breast cancer

$365,402
Joshua Clair Snyder · Duke University · R01 · FY2022 · CA

Epigenetically Engineered Mouse Model for Lung Cancer Therapy

$365,308
Lanlan Shen · Baylor College Of Medicine · R01 · FY2021 · CA

Tumor stem cells and metastatic outcomes in mouse models of prostate cancer

$365,255
Kathleen Kelly · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Visualizing tumor heterogeneity in an immune intact and autochthonous mouse model of breast cancer

$365,225
Joshua Clair Snyder · Duke University · R01 · FY2025 · CA

Resistance to Cancer Therapeutics Through Microenvironment Damage Responses.

$365,200
Peter S Nelson · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA

Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression

$365,200
David Mark Hockenbery · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA

Resistance to Cancer Therapeutics Through Microenvironment Damage Responses.

$365,200
Peter S Nelson · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA

Resistance to Cancer Therapeutics Through Microenvironment Damage Responses.

$365,200
Peter S Nelson · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA

Targeting tumor and its microenvironment using nanotherapeutics for pancreatic cancer

$365,189
Satyanarayana Rachagani · University Of Nebraska Medical Center · R01 · FY2022 · CA

Dual-pronged nano-drug delivery using plant virus-like particles

$365,157
Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2023 · CA

Biochemistry of MT1-MMP activation in malignancy

$365,134
Alex Y Strongin · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · CA

Targeting microRNAs in the tumor microenvironment with pHLIP conjugated next generation chemically modified PNAs

$365,085
Frank J. Slack · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA

Project 2: Analyses of the human GBM microenvironment form clinical trial specimens treated with the oncolytic HSV, rQNestin34v.2

$365,084
E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2025 · CA

Aim/Project 1. Dose-response at single-cell and population levels

$365,067
Peter Karl Sorger · Harvard Medical School · P50 · FY2016 · GM

Exploiting dual-TCR for rescue of CD8 T cell tolerance in adoptive immunotherapy

$365,063
Ryan M Teague · Saint Louis University · R01 · FY2012 · AI

Exploiting dual-TCR for rescue of CD8 T cell tolerance in adoptive immunotherapy

$365,063
Ryan M Teague · Saint Louis University · R01 · FY2011 · AI

Exploiting dual-TCR for rescue of CD8 T cell tolerance in adoptive immunotherapy

$365,063
Ryan M Teague · Saint Louis University · R01 · FY2014 · AI

Actively engaging NK cells during virotherapy to induce neoantigen-specific antitumor immunity

$365,032
Xiaoliu Zhang · University Of Houston · R01 · FY2024 · CA

Comparative Functional Genomics

$364,963
Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Project 1: Priming and propagating immunity against head and neck cancer using targeted radionuclide therapy

$364,957
Zachary Scott Morris · University Of Wisconsin-Madison · P50 · FY2023 · CA

Fast interference-based super-resolution microscope for cancer mechanobiology

$364,939
Warren R Zipfel · Cornell University · R33 · FY2017 · CA

The CXCR3 Chemokine System in Cancer Immunotherapy

$364,930
Andrew D Luster · Massachusetts General Hospital · R01 · FY2019 · CA

Regulation of T cell immunity by stromal cells in autoimmune tissue inflammation

$364,911
Aviv Regev · Dana-Farber Cancer Inst · P01 · FY2016 · AI